Recurrent Ovarian Germ Cell Tumor Active Not Recruiting Phase 2 Trials for Letrozole (DB01006)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02283658Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerTreatment